AURINIA (AUR-VCS_2016-02)

By June 19, 2019 Ongoing/In Follow Up

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis

Leave a Reply